Find Faculty Members at MUSC.

Onder Albayram Ph.D.

Provider Image
  • Assistant Professor
  • College of Medicine
  • Medicine
Academic Focus
  • Brain Aging
  • Neurodegenerative Disorders
  • Heart Failure
Faculty email addresses should not be used to seek medical advice or to make medical appointments. Please visit MyChart for medical appointments or to contact your provider.


Office Location


Dr. Albayram is an Assistant Professor in Medicine in the Department of Medicine, Division of Cardiology and Department of Neuroscience at the Medical University of South Carolina, Co-director of the Christie’s Heart & Brain Program. He is also Affiliated Faculty of the Department of Medicine at Beth Israel Department of Medicine, Harvard Medical School in Boston. In 2009, Dr. Albayram has completed a M.S. in neuropharmacology at the Department of Pharmacological Sciences, University of Southern California in Los Angeles, California. In 2013, he has completed the Ph.D.  in neurobiology at the Institute of Molecular Psychiatry, University of Bonn in Germany. During his PhD, he discovered the novel protective role of the hippocampal endocannabinoid signaling system in brain aging. Dr. Albayram completed his faculty training in Translational Neuroscience perspective at Harvard Medical School. During his time at Harvard Medical School, Dr. Albayram identified the unique cis conformation of tau protein as the early driver of disease in chronic traumatic encephalopathy (CTE) and traumatic brain injury (TBI).

Dr. Albayram’s laboratory focuses on understanding the roles of misfolded proteins and aggregates in heart failure and chronic neurodegenerative disorders, both age and trauma related. He is developing an array of diagnostic tools to identify early pathogenic processes and also determine the primary mechanisms of progression of age-related neurodegenerative disorders. His works were published in prominent journals and highlighted numerous press outlets, including Scientific American, Guardian, The Scientist, TIME and News Week amongst others.